keyword
https://read.qxmd.com/read/38722414/metabolomic-signatures-for-blood-pressure-from-early-to-late-adolescence-findings-from-a-u-s-cohort
#1
JOURNAL ARTICLE
Mingyu Zhang, Wei Perng, Sheryl L Rifas-Shiman, Izzuddin M Aris, Emily Oken, Marie-France Hivert
INTRODUCTION: Metabolite signatures for blood pressure (BP) may reveal biomarkers, elucidate pathogenesis, and provide prevention targets for high BP. Knowledge regarding metabolites associated with BP in adolescence remains limited. OBJECTIVES: Investigate the associations between metabolites and adolescent BP, both cross-sectionally (in early and late adolescence) and prospectively (from early to late adolescence). METHODS: Participants are from the Project Viva prospective cohort...
May 9, 2024: Metabolomics: Official Journal of the Metabolomic Society
https://read.qxmd.com/read/38722076/study-on-the-hypotensive-effect-and-mechanism-of-hawthorn-crataegus-pinnatifida-fruits-and-hyperoside-in-spontaneously-hypertensive-rats
#2
JOURNAL ARTICLE
Bingqing Chi, Meng Zhang, Luping Sun, Hongyan Liu, Zhenhua Tian
Hawthorn fruits have a sweet and sour taste, besides having beneficial therapeutic effects on hyperlipidemia, hypertension, and coronary heart disease, making them widely used in food and clinical medicine. However, their hypotensive effects and potential mechanisms of anti-hypertension still need to be elucidated. This study aims to explore the antihypertensive effect of hawthorn and its monomer hyperoside on spontaneously hypertensive rats through pharmacodynamics, serum metabolomics, and in vivo mechanism studies...
May 9, 2024: Food & Function
https://read.qxmd.com/read/38698395/exploring-machine-learning-strategies-for-predicting-cardiovascular%C3%A2-disease-risk-factors-from-multi-omic-data
#3
JOURNAL ARTICLE
Gabin Drouard, Juha Mykkänen, Jarkko Heiskanen, Joona Pohjonen, Saku Ruohonen, Katja Pahkala, Terho Lehtimäki, Xiaoling Wang, Miina Ollikainen, Samuli Ripatti, Matti Pirinen, Olli Raitakari, Jaakko Kaprio
BACKGROUND: Machine learning (ML) classifiers are increasingly used for predicting cardiovascular disease (CVD) and related risk factors using omics data, although these outcomes often exhibit categorical nature and class imbalances. However, little is known about which ML classifier, omics data, or upstream dimension reduction strategy has the strongest influence on prediction quality in such settings. Our study aimed to illustrate and compare different machine learning strategies to predict CVD risk factors under different scenarios...
May 2, 2024: BMC Medical Informatics and Decision Making
https://read.qxmd.com/read/38690905/circulating-metabolic-biomarkers-and-risk-of-new-onset-hypertension-findings-from-the-uk-biobank
#4
JOURNAL ARTICLE
Yan-Feng Zhou, Yi-Xiang Ye, Jun-Xiang Chen, Yan-Bo Zhang, Yi Wang, Qi Lu, Tingting Geng, Gang Liu, An Pan
OBJECTIVE: The evidence regarding the associations of circulating metabolic biomarkers with hypertension risk is scarce. We aimed to examine the associations between circulating metabolites and risk of hypertension. METHODS: We included 49 422 individuals free of hypertension at baseline with a mean (SD) age of 53.5 (8.0) years from the UK Biobank. Nuclear magnetic resonance spectroscopy was used to quantify 143 individual metabolites. Multivariable-adjusted Cox regression models were used to estimate hazard ratios and 95% confidence intervals (CIs)...
June 1, 2024: Journal of Hypertension
https://read.qxmd.com/read/38690877/altered-gut-microbiota-and-metabolite-profiles-provide-clues-in-understanding-resistant-hypertension
#5
JOURNAL ARTICLE
Jiuqi Guo, Pengyu Jia, Zhilin Gu, Wenyi Tang, Ai Wang, Yingxian Sun, Zhao Li
BACKGROUND: Resistant hypertension is a severe phenotype in hypertension that may be driven by interactions between genetic and environmental factors. Specific changes in gut microbiota and metabolites have been shown to influence cardiovascular disease progression. However, microbial and metabolomic changes associated with resistant hypertension remain elusive. METHODS: In this study, the gut microbiome of 30 participants with resistant hypertension, 30 with controlled hypertension, and 30 nonhypertension was characterized using 16S rRNA amplicon sequencing...
March 11, 2024: Journal of Hypertension
https://read.qxmd.com/read/38690652/coronary-sinus-metabolite-12-13-dihome-is-a-novel-biomarker-for-left-atrial-remodeling-in-patients-with-atrial-fibrillation
#6
JOURNAL ARTICLE
Xixiang Tang, Jiafu Wang, Xiaolan Ouyang, Qian Chen, Ruimin Dong, Yanting Luo, Junlin Zhong, Zhuoshan Huang, Long Peng, Xujing Xie, Jieming Zhu, Zhenda Zheng, Suhua Li
BACKGROUND: 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME) has shown potential in protecting against heart disease, but its relationship with atrial fibrillation (AF) remains unknown. METHODS: Coronary sinus (CS) and femoral vein blood samplings were synchronously collected from AF and non-AF subjects (paroxysmal supraventricular tachycardia or idiopathic premature ventricular complexes) who underwent catheter ablation. First, untargeted metabolomic profiling was performed in a discovery cohort (including 12 AF and 12 non-AF subjects) to identify the most promising CS or femoral vein metabolite...
May 1, 2024: Circulation. Arrhythmia and Electrophysiology
https://read.qxmd.com/read/38689160/the-current-use-of-proteomics-and-metabolomics-in-glomerulonephritis-a-systematic-literature-review
#7
REVIEW
Elin Davies, Andrew Chetwynd, Garry McDowell, Anirudh Rao, Louise Oni
BACKGROUND: Glomerulonephritis inherently leads to the development of chronic kidney disease. It is the second most common diagnosis in patients requiring renal replacement therapy in the United Kingdom. Metabolomics and proteomics can characterise, identify and quantify an individual's protein and metabolite make-up. These techniques have been optimised and can be performed on samples including kidney tissue, blood and urine. Utilising omic techniques in nephrology can uncover disease pathophysiology and transform the diagnostics and treatment options for glomerulonephritis...
April 30, 2024: Journal of Nephrology
https://read.qxmd.com/read/38686877/sex-associated-metabolites-and-incident-stroke-incident-coronary-heart-disease-hypertension-and-chronic-kidney-disease-in-the-regards-cohort
#8
JOURNAL ARTICLE
Catharine A Couch, Zsuzsanna Ament, Amit Patki, Naruchorn Kijpaisalratana, Varun Bhave, Alana C Jones, Nicole D Armstrong, Mary Cushman, W Taylor Kimberly, M Ryan Irvin
BACKGROUND: Sex disparities exist in cardiometabolic diseases. Metabolomic profiling offers insight into disease mechanisms, as the metabolome is influenced by environmental and genetic factors. We identified metabolites associated with sex and determined if sex-associated metabolites are associated with incident stoke, incident coronary heart disease, prevalent hypertension, and prevalent chronic kidney disease. METHODS AND RESULTS: Targeted metabolomics was conducted for 357 metabolites in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) case-cohort substudy for incident stroke...
April 30, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38672436/microbiota-metabolite-profiles-and-dietary-intake-in-older-individuals-with-insomnia-of-short-vs-normal-sleep-duration
#9
JOURNAL ARTICLE
Carmel Even, Faiga Magzal, Tamar Shochat, Iris Haimov, Maayan Agmon, Snait Tamir
Recent evidence suggests that the gut microbiota plays a role in insomnia pathogenesis. This study compared the dietary habits and microbiota metabolites of older adults with insomnia of short vs. normal sleep duration (ISSD and INSD, respectively). Data collection included sleep assessment through actigraphy, dietary analysis using the Food Frequency Questionnaire, and metabolomic profiling of stool samples. The results show that ISSD individuals had higher body mass index and a greater prevalence of hypertension...
March 30, 2024: Biomolecules
https://read.qxmd.com/read/38668345/lactylation-modification-in-cardiometabolic-disorders-function-and-mechanism
#10
REVIEW
Xu Li, Pingdong Cai, Xinyuan Tang, Yingzi Wu, Yue Zhang, Xianglu Rong
Cardiovascular disease (CVD) is recognized as the primary cause of mortality and morbidity on a global scale, and developing a clear treatment is an important tool for improving it. Cardiometabolic disorder (CMD) is a syndrome resulting from the combination of cardiovascular, endocrine, pro-thrombotic, and inflammatory health hazards. Due to their complex pathological mechanisms, there is a lack of effective diagnostic and treatment methods for cardiac metabolic disorders. Lactylation is a type of post-translational modification (PTM) that plays a regulatory role in various cellular physiological processes by inducing changes in the spatial conformation of proteins...
April 12, 2024: Metabolites
https://read.qxmd.com/read/38656940/female-protection-against-diabetic-kidney-disease-is-regulated-by-kidney-specific-ampk-activity
#11
JOURNAL ARTICLE
Hak Joo Lee, Liang Min, Jingli Gao, Shane Matta, Viktor Drel, Afaf Saliba, Ian Tamayo, Richard Montellano, Leila Hejazi, Soumya Maity, Guogang Xu, Brian I Grajeda, Sourav Roy, Kenneth R Hallows, Goutam Ghosh Choudhury, Balakuntalam S Kasinath, Kumar Sharma
Reduced kidney AMPK activity is associated with nutrient stress-induced chronic kidney disease (CKD) in male mice. In contrast, female mice resist nutrient stress-induced CKD. The role of kidney AMPK in sex-related organ protection against nutrient stress and metabolite changes were evaluated in diabetic kidney tubule-specific AMPKγ2KO (KTAMPKγ2KO) male and female mice. In WT males, diabetes increased albuminuria, urinary kidney injury molecule-1, hypertension, kidney p70S6K phosphorylation, and kidney matrix accumulation; these features were not exacerbated with KTAMPKγ2KO...
April 24, 2024: Diabetes
https://read.qxmd.com/read/38639736/lysine-and-salt-sensitive-hypertension
#12
JOURNAL ARTICLE
Lashodya V Dissanayake, Oleg Palygin, Alexander Staruschenko
PURPOSE OF REVIEW: Salt-sensitive (SS) hypertension and its associated kidney damage have been extensively studied, yet proper therapeutic strategies are lacking. The interest in altering the metabolome to affect renal and cardiovascular disease has been emerging. Here, we discuss the effect and potential mechanism behind the protective effect of lysine, an essential amino acid, on the progression of SS hypertension. RECENT FINDINGS: We have recently demonstrated that administering lysine in an SS rodent model can control the progression of hypertension...
April 22, 2024: Current Opinion in Nephrology and Hypertension
https://read.qxmd.com/read/38636578/mechanism-and-functional-substances-of-saiga-antelope-horn-in-treating-hypertension-with-liver-yang-hyperactivity-syndrome-explored-using-network-pharmacology-and-metabolomics
#13
JOURNAL ARTICLE
Wenxing Wu, Rui Liu, Sheng Guo, Wencong Song, Yongqing Hua, Min Hong, Jie Zheng, Yue Zhu, Peng Cao, Jin-Ao Duan
ETHNOPHARMACOLOGICAL RELEVANCE: Saiga antelope horn (SAH) is a traditional Chinese medicine for treating hypertension with liver-yang hyperactivity syndrome (Gan-Yang-Shang-Kang, GYSK), that has a long history of clinical application and precise efficacy, but its mechanism and functional substances are still unknown. Based on the demand for alternative research on the rare and endangered SAH, the group designed and carried out the following studies. AIM OF THE STUDY: The purpose of this research was to demonstrate the functional substances and mechanisms of SAH in the treatment of GYSK hypertension...
April 16, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38632606/landscapes-of-gut-bacterial-and-fecal-metabolic-signatures-and-their-relationship-in-severe-preeclampsia
#14
JOURNAL ARTICLE
Xianxian Liu, Xiaoming Zeng, Xing Li, Siming Xin, Feng Zhang, Faying Liu, Yang Zeng, Jilin Wu, Yang Zou, Xinwei Xiong
BACKGROUND: Preeclampsia is a pregnancy-specific disease leading to maternal and perinatal morbidity. Hypertension and inflammation are the main characteristics of preeclampsia. Many factors can lead to hypertension and inflammation, including gut microbiota which plays an important role in hypertension and inflammation in humans. However, alterations to the gut microbiome and fecal metabolome, and their relationships in severe preeclampsia are not well known. This study aims to identify biomarkers significantly associated with severe preeclampsia and provide a knowledge base for treatments regulating the gut microbiome...
April 17, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38632579/microbiota-derived-acetate-attenuates-neuroinflammation-in-rostral-ventrolateral-medulla-of-spontaneously-hypertensive-rats
#15
JOURNAL ARTICLE
Xiaopeng Yin, Changhao Duan, Lin Zhang, Yufang Zhu, Yueyao Qiu, Kaiyi Shi, Sen Wang, Xiaoguang Zhang, Huaxing Zhang, Yinchao Hao, Fang Yuan, Yanming Tian
BACKGROUND: Increased neuroinflammation in brain regions regulating sympathetic nerves is associated with hypertension. Emerging evidence from both human and animal studies suggests a link between hypertension and gut microbiota, as well as microbiota-derived metabolites short-chain fatty acids (SCFAs). However, the precise mechanisms underlying this gut-brain axis remain unclear. METHODS: The levels of microbiota-derived SCFAs in spontaneously hypertensive rats (SHRs) were determined by gas chromatography-mass spectrometry...
April 18, 2024: Journal of Neuroinflammation
https://read.qxmd.com/read/38621924/clinical-experimental-and-pathophysiological-effects-of-yaq-001-a-non-absorbab-le-gut-restricted-adsorbent-in-models-and-patients-with-cirrhosis
#16
JOURNAL ARTICLE
Jinxia Liu, Jane MacNaughtan, Annarein J C Kerbert, Theo Portlock, Javier Martínez Gonzalez, Yi Jin, Frederick Clasen, Abeba Habtesion, Huoyan Ji, Qin Jin, Alexandra Phillips, Francesco De Chiara, Ganesh Ingavle, Cesar Jimenez, Giacomo Zaccherini, Katherine Husi, Miguel Angel Rodriguez Gandia, Paul Cordero, Junpei Soeda, Lynda McConaghy, Jude Oben, Karen Church, Jia V Li, Haifeng Wu, Aarti Jalan, Pere Gines, Elsa Solà, Simon Eaton, Carrie Morgan, Michal Kowalski, Daniel Green, Amir Gander, Lindsey A Edwards, I Jane Cox, Helena Cortez-Pinto, Thomas Avery, Reiner Wiest, Francois Durand, Paolo Caraceni, Roberto Elosua, Joan Vila, Marco Pavesi, Vicente Arroyo, Nathan Davies, Rajeshwar P Mookerjee, Victor Vargas, Susan Sandeman, Gautam Mehta, Saeed Shoaie, Julian Marchesi, Agustín Albillos, Fausto Andreola, Rajiv Jalan
OBJECTIVE: Targeting bacterial translocation in cirrhosis is limited to antibiotics with risk of antimicrobial resistance. This study explored the therapeutic potential of a non-absorbable, gut-restricted, engineered carbon bead adsorbent, Yaq-001 in models of cirrhosis and acute-on-chronic liver failure (ACLF) and, its safety and tolerability in a clinical trial in cirrhosis. DESIGN: Performance of Yaq-001 was evaluated in vitro . Two-rat models of cirrhosis and ACLF, (4 weeks, bile duct ligation with or without lipopolysaccharide), receiving Yaq-001 for 2 weeks; and two-mouse models of cirrhosis (6-week and 12-week carbon tetrachloride (CCl4)) receiving Yaq-001 for 6 weeks were studied...
April 15, 2024: Gut
https://read.qxmd.com/read/38613058/gut-liver-axis-dysregulation-in-portal-hypertension-emerging-frontiers
#17
REVIEW
Martina Lombardi, Jacopo Troisi, Benedetta Maria Motta, Pietro Torre, Mario Masarone, Marcello Persico
Portal hypertension (PH) is a complex clinical challenge with severe complications, including variceal bleeding, ascites, hepatic encephalopathy, and hepatorenal syndrome. The gut microbiota (GM) and its interconnectedness with human health have emerged as a captivating field of research. This review explores the intricate connections between the gut and the liver, aiming to elucidate how alterations in GM, intestinal barrier function, and gut-derived molecules impact the development and progression of PH. A systematic literature search, following PRISMA guidelines, identified 12 original articles that suggest a relationship between GM, the gut-liver axis, and PH...
April 1, 2024: Nutrients
https://read.qxmd.com/read/38596683/l-fucose-and-fucoidan-alleviate-high-salt-diet-promoted-acute-inflammation
#18
JOURNAL ARTICLE
Wenhua Li, Pengfei Wu, Tianrong Jin, Jialin Jia, Bo Chen, Tingting Liu, Yu Liu, Jie Mei, Bangwei Luo, Zhiren Zhang
Excessive salt intake is a widespread health issue observed in almost every country around the world. A high salt diet (HSD) has a strong correlation with numerous diseases, including hypertension, chronic kidney disease, and autoimmune disorders. However, the mechanisms underlying HSD-promotion of inflammation and exacerbation of these diseases are not fully understood. In this study, we observed that HSD consumption reduced the abundance of the gut microbial metabolite L-fucose, leading to a more substantial inflammatory response in mice...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38596218/association-of-adrenal-steroids-with-metabolomic-profiles-in-patients-with-primary-and-endocrine-hypertension
#19
MULTICENTER STUDY
Robin Knuchel, Zoran Erlic, Sven Gruber, Laurence Amar, Casper K Larsen, Anne-Paule Gimenez-Roqueplo, Paolo Mulatero, Martina Tetti, Alessio Pecori, Christina Pamporaki, Katharina Langton, Mirko Peitzsch, Filippo Ceccato, Aleksander Prejbisz, Andrzej Januszewicz, Christian Adolf, Hanna Remde, Livia Lenzini, Michael Dennedy, Jaap Deinum, Emily Jefferson, Anne Blanchard, Maria-Christina Zennaro, Graeme Eisenhofer, Felix Beuschlein
INTRODUCTION: Endocrine hypertension (EHT) due to pheochromocytoma/paraganglioma (PPGL), Cushing's syndrome (CS), or primary aldosteronism (PA) is linked to a variety of metabolic alterations and comorbidities. Accordingly, patients with EHT and primary hypertension (PHT) are characterized by distinct metabolic profiles. However, it remains unclear whether the metabolomic differences relate solely to the disease-defining hormonal parameters. Therefore, our objective was to study the association of disease defining hormonal excess and concomitant adrenal steroids with metabolomic alterations in patients with EHT...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38587181/interplay-between-plasma-glycine-and-branched-chain-amino-acids-contributes-to-the-development-of-hypertension-and-coronary-heart-disease
#20
JOURNAL ARTICLE
Mateusz Dziedzic, Ewelina Józefczuk, Tomasz J Guzik, Mateusz Siedlinski
BACKGROUND: Higher levels of plasma glycine are linked to a reduced risk, while increased levels of total branched-chain amino acids (tBCAAs) are associated with a higher risk of essential hypertension (HTN) and coronary heart disease (CHD). As these metabolic components are interconnected, analyzing the tBCAAs/glycine ratio may help to understand their interplay in the pathogenesis of cardiovascular disease. METHODS: The Cox regression approach was combined with the development of novel genetic tools for assessments of associations between plasma metabolomic data (glycine, tBCAAs, and tBCAAs/glycine ratio) from the UK Biobank and the development of hypertension and CHD...
April 8, 2024: Hypertension
keyword
keyword
169845
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.